Showing results (471-480 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|May 5, 2017
3-Bromopyruvate enhances TRAIL-induced apoptosis in human nasopharyngeal carcinoma cells through CHOP-dependent upregulation of TRAIL-R2Zhou Can, Song Lele, Zhang Zhirui, et al.
Anti-Cancer Drugs|July 11, 2017
Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cellsLan Li, Dejun Cui, Limin Ye, et al.
Anti-Cancer Drugs|June 29, 2017
A palladium(II)-saccharinate complex of terpyridine exerts higher anticancer potency and less toxicity than cisplatin in a mouse allograft modelYuksel Cetin, Zelal Adiguzel, Hivda U Polat, et al.
Anti-Cancer Drugs|October 14, 2005
Chemo-inducible gene therapyJames J Mezhir, Hank Schmidt, Bakhtiar Yamini, et al.
Anti-Cancer Drugs|October 14, 2005
In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenesGerhard Kelter, Nigel J Sweeney, Katja Strohfeldt, et al.
Anti-Cancer Drugs|October 14, 2005
Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I-II studySebastian Stier, Caroline Koll, Thomas Neuhaus, et al.
Anti-Cancer Drugs|October 14, 2005
Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancerM Zwitter, V Kovac, U Smrdel, et al.
Anti-Cancer Drugs|October 14, 2005
Lasting remission following multimodal treatment in a patient with metastatic breast cancerH J Stemmler, H Menzel, C Salat, et al.
Anti-Cancer Drugs|October 14, 2005
Recurrent and metastatic clivus chordoma: systemic palliative therapy retards disease progressionKatharina Schönegger, Ellen Gelpi, Daniela Prayer, et al.
Anti-Cancer Drugs|December 1, 2005
Interleukin-2 for the treatment of solid tumors other than melanoma and renal cell carcinomaCarlos Grande, Jose Luis Firvida, Víctor Navas, et al.
Pageof 464